POLYMYXIN B
Active substance: polymyxin B
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · POLYMYXIN B SULFATE 500000 [USP'U]/1
United StatesActive
Marketing holder: Fresenius Kabi USA, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- POLYMYXIN B SULFATE · 500000 [USP'U]/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4dae-7217-be2c-028c018d4c4b,01a1208d-425a-7d96-94d4-fecf91fde7d9,01a1208d-89d1-74ac-abc7-3e38348117c5,01a1208e-a657-740b-b42f-67f9977afd7c,01a1208e-ddbc-7bc0-82d5-d5d1732b356a;count=9 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63323-321
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, OPHTHALMIC
Sources
- product · openFDA NDC · 63323-321 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63323-321 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63323-321 · Verified 2026-10-09 · open in source